Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Burning Rock Biotech Ltd stock

Learn how to easily invest in Burning Rock Biotech Ltd stock.

Burning Rock Biotech Ltd is a diagnostics & research business based in the US. Burning Rock Biotech Ltd shares (BNR) are listed on the NASDAQ and all prices are listed in US Dollars. Burning Rock Biotech Ltd employs 1,394 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Burning Rock Biotech Ltd

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – BNR – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Burning Rock Biotech Ltd stock price (NASDAQ: BNR)

Use our graph to track the performance of BNR stocks over time.

Burning Rock Biotech Ltd shares at a glance

Information last updated 2022-07-03.
Latest market close$2.66
52-week range$1.74 - $29.16
50-day moving average $3.32
200-day moving average $9.53
Wall St. target price$13.32
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.27

Buy Burning Rock Biotech Ltd shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
$10
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$1
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you open a Robinhood account
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Axos Bank Self Directed Investing
Stocks
$0
$1,000
$150
when you open an account and deposit at least $1500.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Burning Rock Biotech Ltd stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Burning Rock Biotech Ltd price performance over time

Historical closes compared with the close of $2.66 from 2022-07-01

1 week (2022-06-28) 9.47%
1 month (2022-06-03) 13.68%
3 months (2022-04-05) -74.52%
6 months (2022-01-05) -71.55%
1 year (2021-07-02) -90.44%
2 years (2020-07-02) -90.20%
3 years (2019-07-01) N/A
5 years (2017-07-01) N/A

Burning Rock Biotech Ltd financials

Revenue TTM $536.8 million
Gross profit TTM $364.1 million
Return on assets TTM -23.17%
Return on equity TTM -44.46%
Profit margin -165.19%
Book value $15.83
Market capitalisation $279.8 million

TTM: trailing 12 months

Burning Rock Biotech Ltd share dividends

We're not expecting Burning Rock Biotech Ltd to pay a dividend over the next 12 months.

Have Burning Rock Biotech Ltd's shares ever split?

Burning Rock Biotech Ltd's shares were split on a 1:3 basis on 31 July 2014. So if you had owned 3 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Burning Rock Biotech Ltd shares – just the quantity. However, indirectly, the new 200% higher share price could have impacted the market appetite for Burning Rock Biotech Ltd shares which in turn could have impacted Burning Rock Biotech Ltd's share price.

Burning Rock Biotech Ltd share price volatility

Over the last 12 months, Burning Rock Biotech Ltd's shares have ranged in value from as little as $1.74 up to $29.16. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Burning Rock Biotech Ltd's is -0.1847. This would suggest that Burning Rock Biotech Ltd's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Burning Rock Biotech Ltd has bucked the trend.

Burning Rock Biotech Ltd overview

Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and prognosis prediction tests applicable to a range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples. Its principal products include OncoCompass IO, a corresponding test for liquid biopsy samples; OncoScreen IO, a pan-cancer test for tissue samples; OncoCompass Target, a ctDNA liquid biopsy-based test for NSCLC; ColonCore for assessing microsatellite loci related to MSI status and detecting mutations in genes associated with gastrointestinal cancers; and OncoScreen ParpMatch and OncoCompass ParpMatch to target critical genes associated with homologous recombination deficiency. In addition, the company has development and commercialization agreement with Myriad Genetics, Inc. to in-license Myriad myChoice tumor testing in China; and licensing agreement with Oncocyte Corporation to in-license DetermaRx, a risk stratification test for early stage lung cancer patients in China. It has collaborations on clinical trials and research studies with AstraZeneca, Bayer, Johnson & Johnson, CStone, BeiGene, Abbisko Therapeutics, and IMPACT Therapeutics and Merck KGaA.

Frequently asked questions

What percentage of Burning Rock Biotech Ltd is owned by insiders or institutions?
Currently 5.825% of Burning Rock Biotech Ltd shares are held by insiders and 64.028% by institutions.
How many people work for Burning Rock Biotech Ltd?
Latest data suggests 1,394 work at Burning Rock Biotech Ltd.
When does the fiscal year end for Burning Rock Biotech Ltd?
Burning Rock Biotech Ltd's fiscal year ends in December.
Where is Burning Rock Biotech Ltd based?
Burning Rock Biotech Ltd's address is: No. 5, Xingdao Ring Road North, Guangzhou, China, 510005
What is Burning Rock Biotech Ltd's ISIN number?
Burning Rock Biotech Ltd's international securities identification number is: US12233L1070

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site